title: Neuroprotection after ischemic stroke by activation of angiotensin receptor type 2: why clinical data do not fit the paradigm?
authors.affiliation: aDepartment of Surgery, Faculty of medicine, Montreal Heart Institute, Research Centre, Université de Montréal, Montréal, Quebec, Canada bDipartimento Scienze della Salute, Clinica Nefrologica, Universita' Milano-Bicocca, Monza, Italy.
authors.forename: Eric
authors.initials: E
authors.lastname: Thorin
authors.forename: Giovanna
authors.initials: G
authors.lastname: Castoldi
authors.forename: Andrea
authors.initials: A
authors.lastname: Stella
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000737:chemistry*; D000818:Animals; D008297:Male; D018919:Neovascularization, Physiologic; D044139:Receptor, Angiotensin, Type 2 / Q000378:metabolism*; D020521:Stroke / Q000188:drug therapy*
chemical_list: D043925:Angiogenesis Inducing Agents; D044139:Receptor, Angiotensin, Type 2